Economical and robust manufacturing technology
Commercial scale manufacturing available.
Leuprorelin Acetate

Indication: Prostate cancer, endometriosis, uterine leiomyomata, precocious puberty, breast cancer

FDA Registration No.: 29355

CFDA Certificate No.: ZJ20150025